Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
May 9, 2019
The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
Islam M Miligy, Michael S Toss, Kylie L Gorringe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 16, 2018
Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
The Breast Journal
|
July 19, 2019
Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution
Islam M Miligy, Michael S Toss, Hazem Khout, et al.
Histopathology
|
February 7, 2019
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Rita Haj-Ahmad, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2019
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Breast Cancer Research and Treatment
|
May 24, 2020
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
Chitra Joseph, Mansour Alsaleem, Nnamdi Orah, et al.
Breast Cancer Research : BCR
|
July 31, 2019
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
Sergey Klimov, Islam M Miligy, Arkadiusz Gertych, et al.
British Journal of Cancer
|
March 24, 2020
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Michael S Toss, Asima Abidi, Dorothea Lesche, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2019
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Histopathology
|
June 7, 2024
Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study
Islam M Miligy, Rachna Awasthi, Yasmeen Mir, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
May 9, 2019
The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
Islam M Miligy, Michael S Toss, Kylie L Gorringe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 16, 2018
Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
The Breast Journal
|
July 19, 2019
Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution
Islam M Miligy, Michael S Toss, Hazem Khout, et al.
Histopathology
|
February 7, 2019
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Rita Haj-Ahmad, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2019
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Breast Cancer Research and Treatment
|
May 24, 2020
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
Chitra Joseph, Mansour Alsaleem, Nnamdi Orah, et al.
Breast Cancer Research : BCR
|
July 31, 2019
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
Sergey Klimov, Islam M Miligy, Arkadiusz Gertych, et al.
British Journal of Cancer
|
March 24, 2020
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Michael S Toss, Asima Abidi, Dorothea Lesche, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 9, 2019
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
Michael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Histopathology
|
June 7, 2024
Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study
Islam M Miligy, Rachna Awasthi, Yasmeen Mir, et al.
Page
of 5